We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

apceth and Indivumed to Develop Biomarker Platform for Targeted Cellular Therapies

Product News   Feb 23, 2012

 
apceth and Indivumed to Develop Biomarker Platform for Targeted Cellular Therapies
FURTHER INFORMATION
 
 
 

Related Product News

Selonterra To Present Alzheimer’s Disease Therapy Program at Biotech Showcase™ 2020

Product News

Selonterra, a biotechnology company with the aim of discovering therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks, has announced a presentation at the Biotech Showcase™ 2020.

READ MORE

Expedeon Approves Future Focus on DNA Manufacturing For Gene Therapy

Product News

Expedeon shareholders have approved the sale of its proteomics and immunology business, as well as the proposed name change to 4basebio AG, reflecting the Company’s future focus on DNA manufacturing for gene therapy and gene vaccines.

READ MORE

Collaborative to Fund Lung Cancer Immunotherapy Clinical Trial

Product News

Vaccitech has announced that it has entered into a clinical partnership with Cancer Research UK to develop a novel immunotherapy as a treatment option for patients with non-small cell lung cancer.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE